drugset

drugset / Trial / NCT00092859

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ↗

Phase 3 Completed 1500 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 2-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients.

Timeline

Start: 2003-08
Primary completion: 2005-06
Completion: 2005-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MK0557	Small molecule	—	—

Indications